HUMANISIERTE ANTIKÖRPER FÜR CD3

European patent · EP3668898 · In force

Register entry

Publication number
EP3668898
Application number
EP18765358
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 13, 2018
Published
Jun 24, 2020
Granted
Jul 5, 2023
Protection ends at the latest
Aug 12, 2038
Next annual fee due
Aug 31, 2027
IPC classes
C07K 16/28 (2006.01)
C07K 16/32 (2006.01)
Priority
EP 17186128 14.08.2017
PCT application
PCT/EP2018/071872 13.08.2018
PCT publication
WO2019/034580 21.02.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Sep 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  3. Sep 1, 2024

    Next annual fee due on

    Next annual fee due on
    31.08.2024 → 31.08.2025

    Published in Swissreg on 01.09.2024

  4. May 15, 2024

    Change

    Published in Swissreg on 15.05.2024

  5. Sep 1, 2023

    Change

    Published in Swissreg on 01.09.2023

  6. Jul 5, 2023

    Granted

    Published in Swissreg on 05.07.2023

Parties

Holder

MorphoSys AG

Semmelweisstrasse 7, 82152 Planegg, DE

Inventor

TILLER, Thomas

81475 München, DE

BÜLTMANN, Andreas

82152 Planegg, DE

NEUGEBAUER, Julia

81677 München, DE

RUNZ, Steffen

81377 München, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.